Figuring out whether you need a prescription for a therapeutic vape can feel like trying to follow two sets of rules at once. Schedule 3 vs Schedule 4 Therapeutic Vapes Explained comes down to one key point: access through a pharmacy does not mean open retail access. Nicotine strength, age, clinical needs, and local laws can all shape the pathway.
In Australia, therapeutic vapes are intended only for smoking cessation or nicotine-dependence management. They are not recreational products. A pharmacist or prescriber must decide whether a vape is suitable for your circumstances.
Clinical review note: A registered pharmacist, GP, or tobacco-treatment specialist should review individual treatment choices. Rules and product availability can change, so confirm current advice with official TGA and state or territory health guidance.
Schedule 3 vs Schedule 4 Therapeutic Vapes at a Glance
For many people, the main dividing line is a nicotine concentration of 20 mg/mL. Schedule 3 products may be available without a prescription, but only under strict pharmacy conditions. Schedule 4 products generally require a valid prescription.
| Feature | Schedule 3 therapeutic vape | Schedule 4 therapeutic vape |
|---|---|---|
| Medicine schedule | Pharmacist-only medicine | Prescription-only medicine |
| Nicotine concentration | 20 mg/mL or less, including exactly 20 mg/mL | More than 20 mg/mL, or products outside Schedule 3 conditions |
| Prescription needed | No, if all Schedule 3 conditions are met | Yes, from an eligible prescriber |
| Minimum age | 18 years or older | Depends on clinical need and local law |
| Supplier | Participating pharmacy after a consultation | Participating pharmacy after prescription assessment |
| Consultation | In-person pharmacist consultation | Appointment with a medical practitioner or nurse practitioner |
| TGA pathway | Special Access Scheme Category C notification | Usually SAS Category C, SAS Category B, or Authorised Prescriber |
Information checked: 23 September 2026. Federal requirements operate alongside state and territory laws. Local rules can impose extra limits, including restrictions on supply to younger people.
Schedule 3 therapeutic vapes are pharmacist-only products, usually containing nicotine at 20 mg/mL or less. Schedule 4 therapeutic vapes cover products above that threshold, as well as products that do not meet another Schedule 3 supply condition.
Neither pathway allows ordinary retail sales. Vape shops, tobacconists, and convenience stores cannot legally sell therapeutic vapes to consumers. The lawful route always involves a pharmacy and a therapeutic purpose.
What Is a Schedule 3 Therapeutic Vape?
A Schedule 3 therapeutic vape is a pharmacist-only option for eligible adults. It generally covers notified therapeutic vaping goods containing no more than 20 mg/mL nicotine. The pharmacy must also be operating in a state or territory that allows this type of supply.
Can you buy a therapeutic vape without a prescription? Yes, but only through this closely controlled pathway. You must be at least 18, visit a participating pharmacy, and complete an in-person consultation.
What happens during the pharmacist consultation?
This is more than a quick counter purchase. The pharmacist first checks your identity and age, then discusses your smoking or vaping history, nicotine dependence, and previous attempts to quit.
- The pharmacist verifies identification and proof that you are at least 18.
- You discuss smoking, vaping, nicotine use, and past treatment attempts.
- The pharmacist considers nicotine strength, dosage, and product suitability.
- You receive information about risks, informed consent, and other quit options.
- The pharmacist decides whether supply is clinically and legally appropriate.
Someone smoking 15 cigarettes a day, for example, may need different support from someone who only vapes occasionally. The pharmacist may suggest patches, gum, counselling, or prescribed medicine first. A therapeutic vape is not automatic treatment simply because someone asks for one.
Supply is limited to a one-month therapeutic quantity. A person can receive Schedule 3 supply only once in that month. Pharmacists may decline supply if treatment appears unsuitable, stock is unavailable, or legal requirements have not been met.
Not every pharmacy takes part in this pathway. Some do not stock therapeutic vapes or provide consultations. It is worth calling ahead to ask whether the pharmacy offers pharmacist-only therapeutic vape assessments.
The TGA says pharmacists must confirm that supply is clinically appropriate for “smoking cessation and/or the management of nicotine dependence.” That keeps the focus on treatment, rather than turning Schedule 3 access into general retail vape sales.
When Is a Schedule 4 Therapeutic Vape Prescription Required?
A Schedule 4 therapeutic vape generally needs a prescription when the nicotine concentration exceeds 20 mg/mL. This applies regardless of the patient’s age. Products containing more than 50 mg/mL nicotine cannot be supplied.
A registered Australian medical practitioner or nurse practitioner may prescribe a therapeutic vape. They must use professional judgement and follow applicable laws. They may also decide that another treatment would be safer or more helpful.
Situations that may require a prescription
A prescription may be needed in several circumstances. Higher nicotine concentrations are the clearest example. More complex health needs or jurisdiction-specific restrictions can also make the prescription pathway necessary.
- You need a nicotine concentration above 20 mg/mL.
- You are under 18 and supply is legally permitted in your jurisdiction.
- Your state or territory does not allow pharmacist-only Schedule 3 supply.
- A prescriber considers your nicotine dependence or health needs more complex.
- The product does not meet every condition for Schedule 3 pharmacy supply.
People under 18 cannot use the Schedule 3 pharmacist-only pathway. Some states and territories may also ban therapeutic-vape supply to minors, even with a prescription. Families should seek direct advice from a qualified local prescriber.
The Schedule 4 route usually starts with an appointment. A medical practitioner or nurse practitioner will discuss nicotine use, quitting goals, health history, and other treatment options. If a vape is clinically appropriate, they issue a prescription and arrange the relevant TGA access pathway.
A participating pharmacy then dispenses an eligible product. Still, a prescriber is not required to write a prescription, and a pharmacy is not required to stock or supply a prescribed therapeutic vape.
TGA Notified Vape List, ARTG and Access Pathways
The TGA notified vape list is different from the Australian Register of Therapeutic Goods. Notified vapes are unapproved therapeutic goods. Appearing on the notified list does not make them ARTG-registered or ARTG-listed.
Inclusion on the notified list means a sponsor has told the TGA that a product meets the applicable requirements. It does not mean the TGA has individually assessed that product for quality, safety, efficacy, or performance. That difference matters when considering benefits and risks.
Safeguards for therapeutic vaping goods
Therapeutic vaping goods must meet the relevant product standards. These standards cover ingredients, nicotine limits, packaging, labels, devices, and product design. Pharmacies should source and supply eligible products from the current TGA notified vape list.
- Nicotine concentration limits apply to pharmacy supply pathways.
- Packaging and labelling must meet applicable therapeutic product requirements.
- Devices and substances must meet relevant design and ingredient standards.
- Products must support smoking cessation or nicotine-dependence management.
Schedule 3 supply to an eligible adult uses the Special Access Scheme Category C notification pathway. After each eligible supply, the pharmacist must notify the TGA within 28 days. This applies to notified products containing nicotine at 20 mg/mL or less.
For prescribed products, medical practitioners and nurse practitioners can use SAS Category C for eligible patients aged 16 and over. The notification covers the patient, prescriber, product, and therapeutic indication. A meaningful change may require a new notification.
SAS Category B may be used where Category C does not apply. For example, it can apply to younger patients where local law permits. The Authorised Prescriber pathway may also allow approved medical practitioners to prescribe within its conditions.
These pathways are administrative safeguards, not a guarantee that a product will work for everyone. The TGA continues to treat therapeutic vapes as unapproved goods. Before supply, a pharmacist or prescriber should explain what that means.
How to Access Therapeutic Vapes Legally in Australia
Legal access depends on your age, local laws, and treatment needs. Do not classify a vape yourself based only on its label or nicotine number. Let a pharmacist or prescriber determine the appropriate clinical and legal pathway.
- Check your age and the rules in your state or territory.
- Discuss smoking cessation and nicotine-dependence support with a pharmacist or prescriber.
- Confirm whether the suitable product fits Schedule 3 or Schedule 4 conditions.
- Contact a participating pharmacy and ask whether it can supply the product.
- Use only a lawful pharmacy-based supply route.
If you are 18 or older and need nicotine at 20 mg/mL or less, a pharmacist may assess you for Schedule 3 supply. You will still need an in-person consultation. The pharmacy must also confirm that therapeutic vaping suits your situation.
If you need more than 20 mg/mL nicotine, you need a prescription. The same usually applies if you are younger than 18 and local law permits supply. Book an appointment with an Australian-registered medical practitioner or nurse practitioner.
Vape shops, tobacconists, and convenience stores cannot legally sell therapeutic vapes to consumers. That remains true even when a store claims its product helps people quit. Do not treat ordinary retail packaging or online claims as proof of lawful supply.
Call before making a trip to a pharmacy. Ask whether it offers therapeutic-vape consultations, prescription dispensing, and products from the notified list. You can also read how to access therapeutic vapes in Australia and find a participating pharmacy before making contact.
Supply rules, participating providers, and product listings can change. State and territory laws may also differ from national rules. Check current official guidance before seeking treatment or filling a prescription.
Safety, Quitting Support and Better First-Line Options
Therapeutic vapes are not first-line treatments for quitting smoking. Consider them only after discussing established, evidence-based options. No therapeutic vape is risk-free, and none is guaranteed to help someone quit.
First-line support often combines practical guidance with medicines suited to your health needs. A pharmacist, GP, or tobacco-treatment specialist can help you put together a realistic quit plan. For many people, combined support works better than managing cravings alone.
- Behavioural counselling and free Quitline support.
- Nicotine replacement therapy, including patches, gum, and lozenges.
- Approved prescription medicines where clinically suitable.
- A written plan for triggers, cravings, and relapse prevention.
Learn more about evidence-based quit-smoking options before choosing a therapeutic vape. Discuss therapeutic vape nicotine strengths with a health professional rather than guessing. The lowest appropriate nicotine exposure should always be part of that conversation.
Nicotine can cause dependence and side effects. Problems can also arise when products are mixed or more nicotine is used than planned. Keep all devices, pods, and liquids away from children, as accidental nicotine exposure can be dangerous.
Speak with a pharmacist or doctor if you experience side effects or find it hard to reduce nicotine use. Seek tailored advice for pregnancy, mental-health concerns, heart conditions, or medicine interactions. Report serious suspected problems through the appropriate health professional or official reporting process.
The best approach is practical and non-promotional. Use therapeutic vaping only as part of a clinically appropriate plan to quit smoking or manage nicotine dependence. Keep reviewing whether you can reduce nicotine use and move toward safer established supports.
Conclusion
Schedule 3 therapeutic vapes may be supplied without a prescription only to eligible adults through participating pharmacies. They require an in-person pharmacist consultation, nicotine at 20 mg/mL or less, and a one-month supply limit. State and territory laws may add further restrictions.
Schedule 4 therapeutic vapes generally require a valid prescription. This pathway applies to products above 20 mg/mL and other situations outside Schedule 3 conditions. Both routes are pharmacy-based, tightly regulated, and limited to smoking cessation or nicotine-dependence management.
Before seeking a therapeutic vape, talk with a pharmacist or qualified prescriber about quit support. Confirm the rules in your state or territory, then ask whether a nearby pharmacy participates. A clear treatment plan can make the process safer, simpler, and more focused on quitting smoking for good.
